Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

mAbs

Showing results (1561-1570 of 1,779) with videos related to

Pageof 178
Sort By:
Mabs|November 24, 2020
Rabbits transgenic for human IgG genes recapitulating rabbit B-cell biology to generate human antibodies of high specificity and affinityFrancesca Ros, Sonja Offner, Stefan Klostermann, et al.
Mabs|November 2, 2020
CAR-J cells for antibody discovery and lead optimization of TCR-like immunoglobulinsChristian Jost, Diana Darowski, John Challier, et al.
Mabs|February 15, 2020
A functional antibody cross-reactive to both human and murine cytotoxic T-lymphocyte-associated protein 4 via binding to an N-glycosylation epitopeDong Li, Jing Li, Huanyu Chu, et al.
Mabs|January 21, 2020
SPLICELECT™: an adaptable cell surface display technology based on alternative splicing allowing the qualitative and quantitative prediction of secreted product at a single-cell levelChristel Aebischer-Gumy, Pierre Moretti, Romain Ollier, et al.
Mabs|December 18, 2014
Blocking monoclonal antibodies of TIM proteins as orchestrators of anti-tumor immune responseMuhammad Baghdadi, Shintaro Takeuchi, Haruka Wada, et al.
Mabs|December 18, 2014
Framework selection can influence pharmacokinetics of a humanized therapeutic antibody through differences in molecule chargeBing Li, Devin Tesar, C Andrew Boswell, et al.
Mabs|December 18, 2014
A monoclonal antibody against hinge-cleaved IgG restores effector function to proteolytically-inactivated IgGs in vitro and in vivoRandall J Brezski, Michelle Kinder, Katharine D Grugan, et al.
Mabs|December 18, 2014
A general approach to antibody thermostabilizationAudrey D McConnell, Xue Zhang, John L Macomber, et al.
Mabs|August 21, 2015
Antibody-drug conjugates: Intellectual property considerationsUlrich Storz
Mabs|December 23, 2014
Recombinant renewable polyclonal antibodiesFortunato Ferrara, Sara D'Angelo, Tiziano Gaiotto, et al.
Pageof 178

Showing results (1561-1570 of 1,779) with videos related to

Sort By:
Pageof 178
Mabs|November 24, 2020
Rabbits transgenic for human IgG genes recapitulating rabbit B-cell biology to generate human antibodies of high specificity and affinityFrancesca Ros, Sonja Offner, Stefan Klostermann, et al.
Mabs|November 2, 2020
CAR-J cells for antibody discovery and lead optimization of TCR-like immunoglobulinsChristian Jost, Diana Darowski, John Challier, et al.
Mabs|February 15, 2020
A functional antibody cross-reactive to both human and murine cytotoxic T-lymphocyte-associated protein 4 via binding to an N-glycosylation epitopeDong Li, Jing Li, Huanyu Chu, et al.
Mabs|January 21, 2020
SPLICELECT™: an adaptable cell surface display technology based on alternative splicing allowing the qualitative and quantitative prediction of secreted product at a single-cell levelChristel Aebischer-Gumy, Pierre Moretti, Romain Ollier, et al.
Mabs|December 18, 2014
Blocking monoclonal antibodies of TIM proteins as orchestrators of anti-tumor immune responseMuhammad Baghdadi, Shintaro Takeuchi, Haruka Wada, et al.
Mabs|December 18, 2014
Framework selection can influence pharmacokinetics of a humanized therapeutic antibody through differences in molecule chargeBing Li, Devin Tesar, C Andrew Boswell, et al.
Mabs|December 18, 2014
A monoclonal antibody against hinge-cleaved IgG restores effector function to proteolytically-inactivated IgGs in vitro and in vivoRandall J Brezski, Michelle Kinder, Katharine D Grugan, et al.
Mabs|December 18, 2014
A general approach to antibody thermostabilizationAudrey D McConnell, Xue Zhang, John L Macomber, et al.
Mabs|August 21, 2015
Antibody-drug conjugates: Intellectual property considerationsUlrich Storz
Mabs|December 23, 2014
Recombinant renewable polyclonal antibodiesFortunato Ferrara, Sara D'Angelo, Tiziano Gaiotto, et al.
Pageof 178